ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1290

$2.04M Total Retail Price of All Prescriptions

Rank: 9 out of 1290

480 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 13,655 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$113 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 633 538 1 2
NEXIUM 516 368 2 34
ADVAIR DISKUS 399 224 3 37
LISINOPRIL 392 306 4 5
CRESTOR 366 278 5 17
IBUPROFEN 347 233 6 74
MELOXICAM 345 310 7 31
LIDODERM 320 189 8 113
METFORMIN HCL 309 216 9 10
ATENOLOL 296 203 10 18
SIMVASTATIN 295 264 11 1
PLAVIX 290 213 12 32
SINGULAIR 277 154 13 85
METOPROLOL TARTRATE 265 218 14 7
ZOLPIDEM TARTRATE 256 215 15 15
TRIAMTERENE-HCTZ 254 207 16 130
LEVOTHYROXINE SODIUM 242 205 17 4
AMLODIPINE BESYLATE 239 181 18 3
CLOPIDOGREL 229 177 19 24
DIOVAN 214 172 20 53
VOLTAREN 214 149 20 107
CELEBREX 213 155 22 111
DONEPEZIL HCL 213 161 22 13
TRAMADOL HCL 183 138 24 25
DIOVAN HCT 177 157 25 112
ENALAPRIL MALEATE 174 129 26 62
ALENDRONATE SODIUM 165 140 27 39
LOVAZA 164 67 28 131
DOXAZOSIN MESYLATE 157 156 29 64
NAMENDA 155 152 30 27
DICLOFENAC SODIUM 154 121 31 77
EXELON 152 133 32 95
ESCITALOPRAM OXALATE 150 104 33 63
SPIRIVA 145 103 34 75
FUROSEMIDE 138 100 35 9
PENTOXIFYLLINE 132 102 36 251
MEGACE ES 128 95 R 37 480
CITALOPRAM HBR 122 75 38 29
LEXAPRO 118 109 39 173
ALPRAZOLAM 112 107 40 47
AMLODIPINE BESYLATE-BENAZEPRIL 108 108 41 166
ABILIFY 105 55 42 114
LYRICA 104 81 43 94
RANITIDINE HCL 103 91 44 49
SEROQUEL XR 100 66 45 151
JANUVIA 98 71 46 82
TEMAZEPAM 96 95 47 71
TRICOR 96 63 47 194
CYMBALTA 95 44 49 59
AVODART 94 79 50 69
LANTUS 93 43 51 67
SOLARAZE 90 63 52 305
LANSOPRAZOLE 90 61 52 181
KETOCONAZOLE 89 69 54 103
SURE COMFORT 88 50 55 214
MECLIZINE HCL 86 68 56 159
MONTELUKAST SODIUM 86 47 56 189
RAMIPRIL 85 85 58 136
FAMOTIDINE 83 71 59 128
CARVEDILOL 83 55 59 12
CILOSTAZOL 82 80 61 237
VESICARE 80 45 62 104
GLIPIZIDE ER 80 79 62 206
PAROXETINE HCL 80 68 62 84
VENTOLIN HFA 78 34 65 123
NIFEDIPINE ER 77 63 66 110
GLYBURIDE-METFORMIN HCL 77 56 R 66 147
LOSARTAN POTASSIUM 76 76 68 19
METOPROLOL SUCCINATE 75 47 69 14
GLYBURIDE MICRONIZED 74 66 R 70 554
NOVOLIN 70-30 74 49 70 233
INSULIN SYRINGE 72 43 72 76
ATORVASTATIN CALCIUM 71 62 73 23
INVEGA 70 47 74 395
NAPROXEN 69 56 75 115
AZITHROMYCIN 69 61 75 61
GLIPIZIDE 67 56 77 81
TAMSULOSIN HCL 67 66 77 11
FLUTICASONE PROPIONATE 66 56 79 26
HYDROCODONE-ACETAMINOPHEN 66 44 S3 79 6
ENTOCORT EC 66 43 10 79 574
CLONAZEPAM 65 42 82 170
IBANDRONATE SODIUM 65 59 82 290
GABAPENTIN 64 61 84 8
SYMBICORT 62 52 85 109
HYDROCHLOROTHIAZIDE 56 46 86 20
ACETAMINOPHEN-CODEINE 55 33 S3 87 138
HUMULIN 70-30 54 42 88 240
MUPIROCIN 53 46 89 120
NOVOLOG MIX 70-30 53 44 89 272
SEROQUEL 52 24 91 186
LANTUS SOLOSTAR 51 32 92 88
PROAIR HFA 51 43 92 73
SORIATANE 50 31 94 643
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.